These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 4238453)

  • 1. Effect of tetrabenazine on extrapyramidal movement disorders.
    Dalby MA
    Br Med J; 1969 May; 2(5654):422-3. PubMed ID: 4238453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The suppression of involuntary movements with tetrabenazine.
    McLellan DL
    Scott Med J; 1972 Nov; 17(11):367-70. PubMed ID: 4264428
    [No Abstract]   [Full Text] [Related]  

  • 3. Tetrabenazine in the treatment of hyperkinetic movement disorders.
    Kenney C; Jankovic J
    Expert Rev Neurother; 2006 Jan; 6(1):7-17. PubMed ID: 16466307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetrabenazine in the treatment of extrapyramidal dyskinesias.
    Gilligan BS; Wodak J; Veale JL; Munro OR
    Med J Aust; 1972 Nov; 2(19):1054-6. PubMed ID: 4264609
    [No Abstract]   [Full Text] [Related]  

  • 5. Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature.
    Chen JJ; Ondo WG; Dashtipour K; Swope DM
    Clin Ther; 2012 Jul; 34(7):1487-504. PubMed ID: 22749259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of involuntary movement disorders with tetrabenazine.
    Swash M; Roberts AH; Zakko H; Heathfield KW
    J Neurol Neurosurg Psychiatry; 1972 Apr; 35(2):186-91. PubMed ID: 4260957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetrabenazine for involuntary movement disorders.
    Kingston D
    Med J Aust; 1979 Jun; 1(13):628-30. PubMed ID: 158700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tetrabenazine, a monoamine-depleting drug used in the treatment of hyperkinetic movement disorders.
    Guay DR
    Am J Geriatr Pharmacother; 2010 Aug; 8(4):331-73. PubMed ID: 20869622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involuntary movement disorders.
    Still CN
    Neurol Clin; 1984 Feb; 2(1):71-89. PubMed ID: 6239089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias.
    Jankovic J; Orman J
    Neurology; 1988 Mar; 38(3):391-4. PubMed ID: 3279337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical mechanisms and management of choreiform movement disorders.
    de Silva L
    Drugs; 1977 Oct; 14(4):300-10. PubMed ID: 144049
    [No Abstract]   [Full Text] [Related]  

  • 12. Tetrabenazine and movement disorders.
    Asher SW; Aminoff MJ
    Neurology; 1981 Aug; 31(8):1051-4. PubMed ID: 6455607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drugs and motor functions.
    Gordon N
    Dev Med Child Neurol; 1971 Jun; 13(3):384-6. PubMed ID: 4398415
    [No Abstract]   [Full Text] [Related]  

  • 14. Tetrabenazine for extra-pyramidal movement disorders.
    MacCallum WA
    Br Med J; 1970 Mar; 1(5698):760. PubMed ID: 5440565
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of haloperidol in the treatment of extrapyramidal compulsive movement].
    Kivalo E; Weckman N
    Nervenarzt; 1970 Nov; 41(11):567-9. PubMed ID: 4249744
    [No Abstract]   [Full Text] [Related]  

  • 16. Predictive factors for tolerability of tetrabenazine in patients with hyperkinetic movement disorders.
    Sahin T; Yilmaz R; Akbostanci MC
    Parkinsonism Relat Disord; 2020 May; 74():36-37. PubMed ID: 32311641
    [No Abstract]   [Full Text] [Related]  

  • 17. [THE TREATMENT OF EXTRAPYRAMIDAL HYPERKINESIAS WITH SPECIAL REFERENCE TO HUNTINGTON'S CHOREA].
    SATTES H; HASE E
    Psychiatr Neurol Neurochir; 1964; 67():289-98. PubMed ID: 14168888
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug treatment of diseases characterized by abnormal movements.
    Marsden CD
    Proc R Soc Med; 1973 Sep; 66(9):871-3. PubMed ID: 4281483
    [No Abstract]   [Full Text] [Related]  

  • 19. [Changes in the electroencephalogram during treatment with amantadine].
    Ferro-Milone F; Parisen-Toldin P
    Minerva Med; 1971 Oct; 62(82):4004-6. PubMed ID: 5125064
    [No Abstract]   [Full Text] [Related]  

  • 20. Tetrabenazine treatment in movement disorders.
    Paleacu D; Giladi N; Moore O; Stern A; Honigman S; Badarny S
    Clin Neuropharmacol; 2004; 27(5):230-3. PubMed ID: 15602104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.